CHROMA ATE INC. – Trademark Portfolio
Entity Type: 03
CHROMA ATE INC. holds 25 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 19 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 3 Nice Classification classes. Currently, 12 trademarks are registered and 5 are pending. Notable registered marks include CHROMA, GENXPLORE, MAGXTRACT, SOFTPANEL, and CHROMA ATE. The owner is based in TAOYUAN HSIEN.
NO. 66, HWA YA 1 RD.
HWA YA TECHNICAL PARK, KUEI SHAN HSIANG
TAOYUAN HSIEN , TW
Showing of trademarks Trademarks
Trademark Classifications
CHROMA ATE INC.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademarks does CHROMA ATE INC. have?
CHROMA ATE INC. has 25 U.S. trademarks filed with the USPTO. Of these, 12 registered, 5 pending, 4 abandoned, 2 cancelled.
What trademark classes does CHROMA ATE INC. file in?
CHROMA ATE INC. files trademarks across 3 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 35 (Advertising & Business). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are CHROMA ATE INC.'s most well-known trademarks?
CHROMA ATE INC.'s registered trademark portfolio includes well-known marks such as CHROMA, GENXPLORE, MAGXTRACT, SOFTPANEL, and CHROMA ATE. These are among 12 currently registered trademarks in the portfolio.
What is CHROMA ATE INC.'s trademark registration success rate?
CHROMA ATE INC. has a 67% trademark registration rate, with 12 out of 18 resolved applications resulting in successful registration. Currently, 5 applications are pending review.